Full Text
The Full Text of this article is available as a PDF (481.7 KB).
Footnotes
CJC has received funding to attend meetings and conferences from Schering-Plough, Allergy Therapeutics, Meda AB, UCB Pharma, Novartis, and Teva; has undertaken research collaborations with GSK, Novartis, ALK-Abello, Allergy Therapeutics and Leti; and has acted as a consultant for Meda AB, GSK, Novartis, MSD and Allergopharma Joachim Ganzer AB. He is a member of the ADMIT Group